FOXO1 and pulmonary arterial hypertension: Taken together, our data support that decreased endurance in experimental pulmonary hypertension in the SU/Hx model is associated with diaphragmatic and skeletal muscle dysfunction through various mechanisms, including a shift in the skeletal muscle fiber type and muscle atrophy that may be mediated by FoxO1 and inflammatory pathways.